Follow The Filings

STRO position history

The shares of Sutro Biopharma (STRO) that Opaleye Management Inc. reported in each quarter’s 13F.

Equity, COM SHS

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q4: 381,342 shares, $4.4M, 0.58% of portfolio, New
  2. 2026 Q1: 190,671 shares, $4.7M, 0.63% of portfolio, Reduce −50.0%
  3. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders